近期国内药物领域投融资事件恩瑞恺诺:细胞疗法——A轮华龛生物:细胞药物载体——B+轮爱科百发:呼吸及儿科新药——IPO申请新元素医药:小分子创新药——IPO申请康霖生物:基因疗法——A+轮拓领博泰:免疫疾病小分子新药——A+轮济因生物:细胞疗法——A+轮国昱堂:中医药现代化——天使轮劲方医药:创新药——上市01恩瑞恺诺生物完成逾2亿元A轮融资9月15日融资公司:深圳恩瑞恺诺生物技术有限公司Rui ...
Source Link近期国内药物领域投融资事件恩瑞恺诺:细胞疗法——A轮华龛生物:细胞药物载体——B+轮爱科百发:呼吸及儿科新药——IPO申请新元素医药:小分子创新药——IPO申请康霖生物:基因疗法——A+轮拓领博泰:免疫疾病小分子新药——A+轮济因生物:细胞疗法——A+轮国昱堂:中医药现代化——天使轮劲方医药:创新药——上市01恩瑞恺诺生物完成逾2亿元A轮融资9月15日融资公司:深圳恩瑞恺诺生物技术有限公司Rui ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.